Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): Implications for angiotensin II signalling pathways

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2804-2809

  Calò, Lorenzo A ^a   Puato, Massimo ^a   Schiavo, Silvia ^a   Zanardo, Marco ^a   Tirrito, Carmen ^a   Pagnin, Elisa ^a   Balbi, Giulia ^a   Davis, Paul A ^b   Palatini, Paolo ^a   Pauletto, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin II; Gitelman's syndrome; Intima media thickness; NO dependent dilation; Vascular remodeling

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; NITRIC OXIDE;

ADULT; ARTICLE; ATHEROGENESIS; BARTTER SYNDROME; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GITELMAN SYNDROME; HUMAN; INTIMA; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANGIOTENSIN II; BARTTER SYNDROME; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; FEMALE; GITELMAN SYNDROME; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; SYMPORTERS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION; YOUNG ADULT;

EID: 58549102923     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn118     Document Type: Article

References (39)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
2. Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 2006; 21: 850-853
3. Undurti N Das. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: 155-162
4. Olsen MH, Wachtell K, Neland K et al. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press 2005; 14: 177-183
5. Lonn E, Yusuf S, Dzavik V et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103: 919-925
6. Pauletto P, Chiavegato A, Giuriato L et al. Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype. Circ Res 1994; 74: 774-788
7. Pauletto P, Da Ros S, Capriani A et al. Smooth muscle cell types at different aortic levels and in microvasculature of rabbits with renovascular hypertension. J Hypertens 1995; 13(Pt 2): 1679-1685
8. Naesens M, Steels P, Verberckmoes R et al. Bartter's and Gitelman's syndromes: from gene to clinic. Nephron Physiol 2004; 96: 65-78
9. Calò LA. Vascular tone control in humans: the utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-966
10. Calò LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12: 17-26
11. Calò LA, Pessina AC. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007; 25: 259-264
12. Palatini P, Graniero G, Mormino P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST trial. Circulation 1994; 90: 2870-2876
13. Sartori M, Semplicini A, Siffert W et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003; 42: 909-914
14. Touboul PJ, Hennerici MG, Meairs S et al. Mannheim intima-media thickness consensus on behalf of the advisory board of the third watching the risk symposium 2004, 13th European Stroke Conference, Mannheim, Germany, May 14, 2004. Cerebrovascular Diseases 2004; 18: 346-349
15. Pauletto P, Palatini P, Da Ros S et al. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999; 19: 1231-1237
16. Deanfield J, Donald A, Ferri C. Endothelial function and dysfunction: Part I. Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 7-17
17. Gemignani V, Faita F, Ghiadoni L et al. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 2007; 26: 393-404
18. Calo L, Davis PA, Milani M et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12-17
19. Calo L, D'Angelo A, Cantaro S et al. Increased urinary NO2-/NO2-and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis 1996; 27: 874-879
20. Mehta PK and Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: 82-97
21. Touyz RM. Role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155-164
22. Ruiz Ortega M, Ruperez M, Esteban V et al. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 2003; 5: 73-79
23. Dzau VJ and Lopez-Ilasaca M. Searching for transcriptional regulators of Ang II-induced vascular pathology. J Clin Invest 2005; 115: 2319-2322
24. Zhan Y, Brown C, Maynard E et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115: 2508-2516
25. Calò LA, Davis PA, Pagnin E et al. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndromes. J Hum Hypertens 2007; 100: 2309. Advance online publication: doi:10;.1038/sj.jhh
26. Calò L, Sartore G, Bassi A et al. Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 1998; 16: 1001-1008
27. Davis PA, Mussap M, Pagnin E et al. Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transpl 2006; 21: 1697-1701
28. Calò LA, Pagnin E, Davis PA et al. Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for Angiotensin II signalling. Nephrol Dial Transplant 2003; 18: 1518-1525
29. Pagnin E, Davis PA, Sartori M et al. Rho kinase and PAI-1 in Bartter's/ Gitelman's syndromes: relationship to angiotensin II signaling. J Hypertens 2004; 22: 1963-1969
30. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554
31. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 2001; 37: 1047-1052
32. Pagnin E, Semplicini A, Sartori M et al. Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes. Relevance for the pathophysiology of hypertension. Am J Hypertens 2005; 18: 1200-1205
33. Volpe M, Musumeci B, De Paolis P et al. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular diseases? J Hypertens 2003; 21: 1429-1443
34. Schiffrin EL, Park JB, Intengam HD et al. Correction of arterial structure and endothelial dysfunction in humans essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-1659
35. Savoia C, Tabet F, Yao G et al. Negative regulation of Rho/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005; 23: 1037-1045
36. Kurisu S, Ozono R, Oshima T et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003; 41: 99-107
37. Davis PA, Pagnin E, Semplicini A et al. Insulin signaling, glucose metabolism and the angiotensin II signaling system. Studies in Bartter's/ Gitelman's syndromes. Diabetes Care 2006; 29: 469-471
38. Calò LA, Davis PA, Palatini P et al. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension. J Hum Hypertens 2007; 21: 904-906
39. Abadir PM, Periasamy A, Carey RM et al. Angiotensin II type 2 receptor bradykinin B2 receptor functional heterodimerization. Hypertension 2006; 48: 316-22